BIO CEO & Investor Conference 2021

/by

Engage with global investors, CEOs, and executives at BIO CEO & Investor Digital Conference, February 16-18, 2021. Attendees can expect interactive and on demand sessions spread across two days covering a mix of therapeutic areas, business development, digital health, patient advocacy, public policy, and next generation biotherapeutics, along with added content relevant to industry responses to COVID-19.

About Biojo Sciences

Biojo Sciences is a global biopharmaceutical company developing novel clinical-stage therapies that improve patient and family lives. With locations in Bethesda, Maryland, and Seoul, South Korea, we in-license, invest, and develop promising clinical-stage drug assets.